2021 Rheumatology Year in Review (1.7.2022)

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.

My Top 10 list
1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod
2. New FDA Indications
3. New Biologics for Lupus
4. Super "H" Hydroxychloroquine
5. Zoomatology
6. Avacopan
7. Tocilizumab
8. FDA & JAK inhibitor warnings
9. New Biologics for GCA
10. IL-23 Inhibitors

[mohammedsiddiqui]

Excellent summary of 2021 as usual and much appreciated .